Citadel Advisors’s Pasithea Therapeutics KTTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $33.8K | Buy |
+46,858
| New | +$33.8K | ﹤0.01% | 5547 |
|
2023
Q2 | – | Sell |
-1,253
| Closed | -$9.75K | – | 6174 |
|
2023
Q1 | $9.75K | Buy |
+1,253
| New | +$9.75K | ﹤0.01% | 5522 |
|
2022
Q2 | – | Sell |
-3,647
| Closed | -$95K | – | 6522 |
|
2022
Q1 | $95K | Buy |
+3,647
| New | +$95K | ﹤0.01% | 5679 |
|